Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Posts Tagged ‘tenax’

Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference

Posted by fidest press agency su mercoledì, 6 febbraio 2019

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing drugs that address diseases with high unmet medical need, today announced that management is scheduled to present and conduct one-on-one meetings at the 2019 BIO CEO & Investor Conference to be held in New York, NY on February 11th and 12th. Anthony DiTonno, Chief Executive Officer, is scheduled to present on Tuesday, February 12th at 2:15 p.m. Eastern Time.Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying and developing drugs that address diseases with high unmet medical need. The Company has a world-class scientific team including recognized global experts in pulmonary hypertension. The Company owns the North American rights to develop and commercialize levosimendan and has initiated a Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). For more information, visit http://www.tenaxthera.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »